1. Home
  2. ECX vs DAWN Comparison

ECX vs DAWN Comparison

Compare ECX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ECARX Holdings Inc. Ordinary shares

ECX

ECARX Holdings Inc. Ordinary shares

HOLD

Current Price

$1.55

Market Cap

560.1M

Sector

Technology

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$10.31

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECX
DAWN
Founded
2017
2018
Country
China
United States
Employees
1918
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.1M
1.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ECX
DAWN
Price
$1.55
$10.31
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$27.11
AVG Volume (30 Days)
2.7M
1.8M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$825.35
$47.48
Revenue Next Year
$35.50
$31.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.60
52 Week Low
$0.76
$5.64
52 Week High
$3.25
$13.20

Technical Indicators

Market Signals
Indicator
ECX
DAWN
Relative Strength Index (RSI) 42.58 42.37
Support Level $1.27 $10.07
Resistance Level $1.77 $10.68
Average True Range (ATR) 0.16 0.64
MACD -0.00 -0.20
Stochastic Oscillator 9.74 9.56

Price Performance

Historical Comparison
ECX
DAWN

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: